Neurodegenerative disorders

Byaibio

Neurodegenerative disorders are an age-related disease category in which cellular senescence is implicated as a crucial developmental mechanism, linking brain aging to disease progression. They are also discussed as a major framework for comparing non-coding RNA evidence across conditions, and as a disease class associated with disruption of epigenetic regulatory mechanisms. In this context, cellular senescence is highlighted as a key driver, while long non coding rnas are described as regulators of amyloid- and synuclein-related processes across major neurodegenerative disorders. Recent literature emphasizes mechanistic integration of autophagy, senescence, and brain aging, including neuroprotective implications of intermittent fasting, and broader epigenome-editing approaches that may inform therapeutic discovery. Overall, the category spans multiple molecular layers—aging, epigenetic control, and ncRNA-mediated regulation—rather than a single disease mechanism.

Aging and cellular senescence

  • Neurodegenerative disorders are described as age-related diseases whose development is linked to cellular senescence and aging, with senescence playing a crucial role in disease development. (PMID:41811567)
  • A 2026 Cellular and Molecular Neurobiology paper (PMID:41811567) connects autophagy, cellular senescence, and brain aging, framing intermittent fasting as a neuroprotective intervention.
  • The disease category is explicitly used to anchor the interplay between aging biology and neurodegeneration in the abstract. (PMID:41811567)

Non-coding RNA mechanisms

  • A 2026 Metabolism Open synthesis (PMID:41908556) uses neurodegenerative disorders as the major comparison framework for ncRNA evidence across multiple conditions.
  • long non coding rnas were discussed across major neurodegenerative disorders as regulators of amyloid/synuclein-related processes. (PMID:41908556)
  • The paper applies an axis-based, evidence-tiered mechanistic approach to non-coding RNA biology in neurodegeneration. (PMID:41908556)

Epigenetic regulation

  • Neurodegenerative disorders are listed among human disease categories linked to disruption of epigenetic regulatory mechanisms. (PMID:41836275)
  • A 2026 Current Opinion in Biomedical Engineering review (PMID:41836275) highlights CRISPR tools for biological discovery and therapeutics, relevant to epigenome rewriting in disease contexts.
  • The abstract places neurodegeneration within a broader set of diseases affected by epigenetic dysregulation. (PMID:41836275)